The Epstein-Barr virus ZEBRA protein activates transcription from the early lytic F promoter by binding to a promoter-proximal AP-1-like site

Journal of General Virology

Volumn 83, Issue 8, 2002, Pages 2007-2014

  Zetterberg, Henrik ^a   Jansson, Ann ^a   Rymo, Lars ^a   Chen, Fu ^a   Karlsson, Ann ^a   Klein, Georg ^a   Brodin, Bertha ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; IMMEDIATE EARLY PROTEIN BZLF1; LEUCINE ZIPPER PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE REPRESSION; GENETIC CODE; LATENT PERIOD; LATENT VIRUS INFECTION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY SEQUENCE; REPORTER GENE; TRANSCRIPTION INITIATION; VIRUS GENOME;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0036329853     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-8-2007     Document Type: Article

References (45)

1. EBV persistence in memory B cells in vivo
2. DNA sequence and expression of the B95-8 Epstein-Barr virus genome
3. Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells
4. A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus
5. Host factors LR1 and Sp1 regulate the Fp promoter of Epstein-Barr virus
6. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA
7. A specific isoform of hnRNP D interacts with DNA in the LR1 heterodimer: Canonical RNA binding motifs in a sequence-specific duplex DNA binding protein
8. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
9. Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos
10. Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis
11. Replication of Epstein-Barr virus within the epithelial cells of oral 'hairy' leukoplakia, an AIDS-associated lesion
12. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen
13. Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8
14. The regulation of transcription by phosphorylation
15. Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children
16. The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters
17. Epstein-Barr virus and its replication
18. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: Implications of the nuclear import of plasmids
19. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle
20. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael
21. A novel form of Epstein-Barr virus latency in normal B cells in vivo
22. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell
23. Characterization of the Epstein-Barr virus Fp promoter
24. Rapid and quantitative recovery of DNA fragments from gels by displacement electrophoresis (isotachophoresis)
25. Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation
26. Epstein-Barr virus
27. The 5′ flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells
28. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle
29. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes
30. The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1
31. Extraction and purification of RNA
32. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site
33. DNA sequencing with chain-terminating inhibitors
34. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes
35. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: Lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines
36. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group 1 Burkitt lymphoma cell lines
37. Reactivation of Epstein-Barr virus: Regulation and function of the BZLF1 gene
38. Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor
39. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes
40. ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter
41. Epstein-Barr virus and the B cell: That's all it takes
42. Identification of a novel promoter located within the BamHI Q region of the Epstein-Barr virus genome for the EBNA 1 gene
43. Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication
44. TRANSFAC: An integrated system for gene expression regulation
45. Relative levels of EBNA 1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection